about
Sphingosine-1-Phosphate Signaling in Immune Cells and Inflammation: Roles and Therapeutic PotentialSphingosine-1-phosphate in chronic intestinal inflammation and cancerExport of sphingosine-1-phosphate and cancer progressionSpns2, a transporter of phosphorylated sphingoid bases, regulates their blood and lymph levels, and the lymphatic networkEstradiol induces export of sphingosine 1-phosphate from breast cancer cells via ABCC1 and ABCG2.Stress-induced dynamic regulation of mitochondrial STAT3 and its association with cyclophilin D reduce mitochondrial ROS productionAdvances in the management of peritoneal mesotheliomaLysophosphatidic acid stimulates gastric cancer cell proliferation via ERK1-dependent upregulation of sphingosine kinase 1 transcription.Current treatment options for colon cancer peritoneal carcinomatosis.An improved syngeneic orthotopic murine model of human breast cancer progressionSphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis.Successful perioperative management of factor X deficiency associated with primary amyloidosis.At what age should screening mammography be recommended for Asian women?Chylothorax after blunt traumaAnimal models for exploring the pharmacokinetics of breast cancer therapiesDevelopment of a metastatic murine colon cancer model.The evolution of the role of surgery in the management of breast cancer lung metastasis.The role of sphingosine-1-phosphate in breast cancer tumor-induced lymphangiogenesis.Inverted Meckel's diverticulum as a cause of occult lower gastrointestinal hemorrhage.High expression of ATP-binding cassette transporter ABCC11 in breast tumors is associated with aggressive subtypes and low disease-free survivalThe phosphorylated prodrug FTY720 is a histone deacetylase inhibitor that reactivates ERα expression and enhances hormonal therapy for breast cancer.Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer.Resection of the primary tumor improves survival in metastatic breast cancer by reducing overall tumor burden.Interstitial Fluid Sphingosine-1-Phosphate in Murine Mammary Gland and Cancer and Human Breast Tissue and Cancer Determined by Novel Methods.Cross-talk between LPA1 and epidermal growth factor receptors mediates up-regulation of sphingosine kinase 1 to promote gastric cancer cell motility and invasion.Export and functions of sphingosine-1-phosphate.Does removal of the primary tumor in metastatic breast cancer improve survival?K63-linked polyubiquitination of transcription factor IRF1 is essential for IL-1-induced production of chemokines CXCL10 and CCL5.Chemokines, chemokine receptors and the gastrointestinal system.DNA damage response and sphingolipid signaling in liver diseases.Metastatic triple-negative breast cancer is dependent on SphKs/S1P signaling for growth and survival.Modified breast cancer model for preclinical immunotherapy studies.The roles of bile acids and sphingosine-1-phosphate signaling in the hepatobiliary diseases.Angiopoietin pathway gene expression associated with poor breast cancer survival.Genomic landscape of colorectal cancer in Japan: clinical implications of comprehensive genomic sequencing for precision medicine.Update on the diagnosis and management of malignant phyllodes tumors of the breast.Operation with less adjuvant therapy for elderly breast cancer.Successful intravenous catheterization by medical students.Murine model of long-term obstructive jaundice.Host sphingosine kinase 1 worsens pancreatic cancer peritoneal carcinomatosis.
P50
Q26766425-053AD3A0-4EB1-49E0-837D-CF79629EB7F8Q26852824-AFA0A2D4-4872-4EBE-979D-37B4EFEB651CQ27009557-E84A178D-6E25-40C1-A67E-40A6D4BEF0A4Q28591658-124827AE-EDFF-44CD-952C-C4B9FE11E327Q33796082-4F63525D-9A69-403F-A4FB-495816AA5160Q33885665-60354D3F-EAF5-4D6B-91E9-05DFA815AC8CQ34137322-72376E6B-CD35-4345-8C98-FA12632EA686Q34165938-DF155DA1-BBA7-491C-AB71-7BC2C91FD093Q34207816-CF01F51C-B649-496E-BFA5-C120C6A26793Q34250295-C3FF2701-74ED-4F12-BB49-955F0BA09FC8Q34251293-142C6CA9-88D5-45C1-9A16-77E2B3BD01F5Q35690760-8A0853C5-D288-48D6-B6BF-1B73AF25A9FFQ35928949-E5561191-E102-40D4-AE4F-5F3758BC842BQ36042242-7ADCD47C-EF6B-46BB-AC1C-6DB6379D089DQ36093956-627C7188-57EA-4215-8CDF-7A098523292CQ36157061-426C4E63-6606-4A7A-9279-EDA28DBB4E4FQ36186296-3FCCE4DD-EB77-4BE7-8720-4778009C52A6Q36241051-0D0D11D6-0263-4575-83A4-4C6D1A1A6664Q36395405-3ED30F5A-AA0B-402A-9A6F-631917E37B73Q36576187-CE5969D6-F666-4769-A8E8-FC9EBF70AA30Q36579794-5FEB9378-52D3-493C-AE2F-4F3F2E9B1AC4Q36627430-99F97647-57EF-4661-A6E6-28B652519124Q36875703-F7514DDC-428D-425F-ABF9-7B4127B73AE7Q37100281-0C855C88-3FE0-4D5D-A1AA-EAA56DD313B9Q37391105-AEF453BE-855A-4AFC-AA6B-583B6A4C542BQ37408557-92542224-5016-4717-941E-457F904C8CCEQ37580276-285DC544-6244-4324-80CE-C3952EAF3090Q37686404-1C1CE776-2B7A-4042-A4D0-5FF23B7A4437Q38109160-C2EB23A2-F8D6-4EA2-ABC7-68D9DC274641Q38619642-6DD7324C-9DDA-4CF0-BC73-7AFE2834FE96Q38720294-019ED394-1886-44A3-A8C4-B0A9450A585FQ38749922-E6E41E62-1DF3-4890-BE43-E297B636769EQ38909010-C4B67B1E-A2FF-4E55-99A3-6546CA6721FBQ39034717-AB03878D-C208-46AE-8B70-46DA0BE52E34Q39071381-0BA8C6B1-C61C-4027-9C86-F9FBC6DC9EADQ39192582-BF36288E-081B-46CD-AA15-C1077FDB4124Q39450470-B1EE3B33-7BCD-45C3-900A-FD60C96D88ACQ39450496-41EA48AC-E387-4AC4-845E-7A76BA706C01Q40442443-60445096-1D48-4002-8974-623DFE0E8A2FQ40567317-CDEA6700-B8D9-4F67-ACC3-EB3455747726
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Kazuaki Takabe
@ast
Kazuaki Takabe
@en
Kazuaki Takabe
@es
Kazuaki Takabe
@sl
type
label
Kazuaki Takabe
@ast
Kazuaki Takabe
@en
Kazuaki Takabe
@es
Kazuaki Takabe
@sl
prefLabel
Kazuaki Takabe
@ast
Kazuaki Takabe
@en
Kazuaki Takabe
@es
Kazuaki Takabe
@sl
P108
P106
P108
P21
P31
P496
0000-0002-6435-4241
P569
2000-01-01T00:00:00Z